{"schema_version":"secwatch.filing_event.v1","accession":"0001005286-24-000093","form_type":"8-K","ticker":"LFCR","cik":"0001005286","company_name":"LIFECORE BIOMEDICAL, INC. DE","filed_at":"2024-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.848889+00:00","generated_at":"2026-05-31T16:36:53.563043+00:00","sec_items":["5.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Lifecore Biomedical approves FY2025 Annual Incentive Plan with EBITDA-based bonuses","bullets":["CEO Paul Josephs target bonus 100% of base salary; CFO John D. Morberg 60%.","Plan weighted 80% on Adjusted EBITDA and 20% on four business objectives.","Maximum payout capped at 200% of target; minimum EBITDA threshold required.","Clawback provision under Compensation Recoupment Policy applies to all payments."],"urls":{"canonical":"https://secwatch.observer/filing/0001005286-24-000093","json":"https://secwatch.observer/filing/0001005286-24-000093.json","markdown":"https://secwatch.observer/filing/0001005286-24-000093.md","text":"https://secwatch.observer/filing/0001005286-24-000093.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000093/0001005286-24-000093-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1005286/000100528624000093/lndc-20240718.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T16:36:53.563043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}